Gail Cawkwell Aclaris Therapeutics, Inc. (ACRS) insider trading activity

ACRS Quotes by TradingView

Gail Cawkwell is Chief Medical Officer of Aclaris Therapeutics, Inc.. Currently has a direct ownership of 9,593 shares of ACRS, which is worth approximately $11,415. The most recent transaction as insider was on Jul 01, 2023, when has been sold 5,407 shares (Common Stock) at a price of $10.37 per share, resulting in proceeds of $56,070. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.59K
0% 3M change
0% 12M change
Total Value Held $11,415

Gail Cawkwell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2023
SELL
Payment of exercise price or tax liability
$56,070 $10.37 p/Share
5,407 Reduced 36.05%
9,593 Common Stock
Jul 01 2023
BUY
Exercise of conversion of derivative security
-
15,000 Added 50.0%
15,000 Common Stock

Also insider at

ICPT
INTERCEPT PHARMACEUTICALS, INC. Healthcare
SVP, Med Affairs, Safety & PV
GC

Gail Cawkwell

Chief Medical Officer
Wayne, PA

Track Institutional and Insider Activities on ACRS

Follow Aclaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRS shares.

Notify only if

Insider Trading

Get notified when an Aclaris Therapeutics, Inc. insider buys or sells ACRS shares.

Notify only if

News

Receive news related to Aclaris Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACRS